SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053666
Filing Date
2020-11-13
Accepted
2020-11-12 18:14:09
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-10q_20200930.htm 10-Q 2492264
2 EX-10.1 ovid-ex101_517.htm EX-10.1 661757
3 EX-31.1 ovid-ex311_8.htm EX-31.1 21247
4 EX-31.2 ovid-ex312_6.htm EX-31.2 21511
5 EX-32.1 ovid-ex321_7.htm EX-32.1 8096
6 GRAPHIC g25cb1ylwwia000001.jpg GRAPHIC 10492
7 GRAPHIC g25cb1ylwwia000005.jpg GRAPHIC 36688
8 GRAPHIC g25cb1ylwwia000007.jpg GRAPHIC 10492
9 GRAPHIC g4pm33isegms000001.jpg GRAPHIC 35030
10 GRAPHIC g25cb1ylwwia000003.jpg GRAPHIC 2819
11 GRAPHIC g25cb1ylwwia000006.jpg GRAPHIC 34733
12 GRAPHIC g25cb1ylwwia000002.jpg GRAPHIC 4278
13 GRAPHIC g25cb1ylwwia000004.jpg GRAPHIC 39979
  Complete submission text file 0001564590-20-053666.txt   7767738

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE DOCUMENT ovid-20200930.xml EX-101.INS 1207420
15 XBRL TAXONOMY EXTENSION SCHEMA ovid-20200930.xsd EX-101.SCH 47558
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovid-20200930_cal.xml EX-101.CAL 35235
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovid-20200930_def.xml EX-101.DEF 187378
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovid-20200930_lab.xml EX-101.LAB 375670
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovid-20200930_pre.xml EX-101.PRE 293522
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 201308411
SIC: 2834 Pharmaceutical Preparations